Literature DB >> 17537767

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area.

A Ortqvist1, F Granath, J Askling, J Hedlund.   

Abstract

The 50% reduced overall mortality previously associated with influenza vaccination among the elderly was based on studies neither fully taking into account systematic differences between individuals who accept or decline vaccination nor encompassing the entire general population. A population-based prospective cohort study was performed in Stockholm County (Sweden), including all persons aged > or =65 yrs (n = approximately 260,000), over three influenza seasons: 1998/1999, 1999/2000 and 2000/2001. The relative risks of mortality among vaccinated versus unvaccinated individuals were estimated using Cox's proportional hazards regression adjusted for, and stratified by, demographic factors and comorbid conditions during the three seasons and the respective following off-seasons. Influenza vaccination was associated with an unadjusted reduction in all-cause mortality during the three seasons of 50, 46 and 42%, respectively, which decreased to 14, 19 and 1%, respectively, following adjustment for confounders and differences in mortality between vaccinated and unvaccinated individuals following the influenza season. The numbers needed to treat to prevent one death, during the three seasons, were 297, 158 and 743, respectively. Vaccination remains the most important measure for prevention of influenza complications in elderly people, although the effectiveness in reducing all-cause mortality in elderly persons is lower than previously thought.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537767     DOI: 10.1183/09031936.00135306

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

Authors:  Sucharit Bhakdi; Karl Lackner; Hans-Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11       Impact factor: 3.402

3.  Research priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.

Authors:  Christopher R Carpenter; Kennon Heard; Scott Wilber; Adit A Ginde; Kirk Stiffler; Lowell W Gerson; Neal S Wenger; Douglas K Miller
Journal:  Acad Emerg Med       Date:  2011-06       Impact factor: 3.451

4.  Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Authors:  Lidia Brydak; Julie Roiz; Pascaline Faivre; Camille Reygrobellet
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

5.  Influenza H1N1 vaccination and adverse pregnancy outcome.

Authors:  Jonas F Ludvigsson; Daniela Zugna; Sven Cnattingius; Lorenzo Richiardi; Anders Ekbom; Åke Örtqvist; Ingemar Persson; Olof Stephansson
Journal:  Eur J Epidemiol       Date:  2013-05-29       Impact factor: 8.082

Review 6.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  The management of community-acquired pneumonia in the elderly.

Authors:  Paola Faverio; Stefano Aliberti; Giuseppe Bellelli; Giulia Suigo; Sara Lonni; Alberto Pesci; Marcos I Restrepo
Journal:  Eur J Intern Med       Date:  2013-12-17       Impact factor: 4.487

8.  Influenza vaccination and mortality: differentiating vaccine effects from bias.

Authors:  Bruce Fireman; Janelle Lee; Ned Lewis; Oliver Bembom; Mark van der Laan; Roger Baxter
Journal:  Am J Epidemiol       Date:  2009-07-22       Impact factor: 4.897

Review 9.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 10.  Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

Authors:  C King; J Beard; A C Crampin; A Costello; C Mwansambo; N A Cunliffe; R S Heyderman; N French; N Bar-Zeev
Journal:  Vaccine       Date:  2015-07-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.